FundedIQ
Biotechnology

3T Biosciences: Funding, Investors & Team (Sep 2026)

Founded in 2017, 3T Biosciences is an immunotherapy company headquartered in Menlo Park, California.

www.3tbiosciences.com LinkedIn Menlo Park, United States 11-50 employees
Total raised
$40.0M
Rounds
1
Latest
Series A
Aug 2022

3T Biosciences has raised $40.0M across 1 funding round on record, the most recent a Series A of $40.0M announced in Aug 2022.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

3T Biosciences Company Profile and Key Stats

Total funding raised
$40.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series A
$40.0M in Aug 2022
Employees
11-50
reported band
Headquarters
Menlo Park, United States

Latest funding round on record: Aug 2022.

3T Biosciences Funding Rounds

Date
Round
Amount
Series A
$40.0M

3T Biosciences Founders and Leadership Team

Name
Role
Contact
Marvin Gee
Founder

No contact details are on record for this team yet.

3T Biosciences Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,183
$8.0M
29,878
$7.5M
8,422
$15M

3T Biosciences' latest round of $40.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like 3T Biosciences in Biotechnology and Menlo Park

Companies Similar to 3T Biosciences

SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…

Undisclosed round $960k

DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…

Series B $4.0M

Solstice Oncology is a clinical stage immuno-oncology company

Series A $225M

Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…

Series F $275M

BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…

Series A $116M

Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…

Series B $65.5M

Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…

Seed $7.0M

ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…

Series C $10.0M

EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…

Series A $35.0M

Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…

Convertible Note $3.5M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

3T Biosciences Funding FAQs

What does 3T Biosciences do?

Founded in 2017, 3T Biosciences is an immunotherapy company headquartered in Menlo Park, California.

How much funding has 3T Biosciences raised?

3T Biosciences has raised $40.0M across 1 round on record. The most recent is a Series A of $40.0M announced in Aug 2022.

When did 3T Biosciences last raise funding?

3T Biosciences' most recent funding round on record is a Series A of $40.0M, announced in Aug 2022.

Who founded 3T Biosciences?

FundedIQ lists Marvin Gee (Founder) at 3T Biosciences.

Where is 3T Biosciences headquartered?

3T Biosciences is based in Menlo Park, California, United States.

How many employees does 3T Biosciences have?

3T Biosciences is in the 11-50 employee band.

How does 3T Biosciences' funding compare to other Biotechnology startups?

3T Biosciences' latest round of $40.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.

About FundedIQ's 3T Biosciences Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for 3T Biosciences is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.